Despite the recent price jump, the company's P/S ratio aligns with the industry, indicating less bearish investor sentiment. However, if the P/S falls to match recent growth rates, investors may face disappointment. The company's poor three-year revenue trends and the industry's higher growth expectations make the current share price seem overvalued unless conditions improve.

Guangzheng Eye Hospital Group's shareholders may find the current situation lucrative, given the past five years' consistent 7% annual returns. Monitor the fundamental developments and seek signs of a long-term growth trend.